Conservative Broadcast Media Journalism (OTCMKTS:CBMJ) posted a robust growth of 118% YoY to $2.4 million in 2020.
Development of own social media platform
Mark Schaftlein, CEO of Conservative Broadcast, said the company is excited to report impressive growth in 2020 and meeting the previous set targets. In 2021, the company expects to improve growth through strategic acquisitions. It also plans to develop its social media platform.
Takes over Military Grade Coffee
Conservative Broadcast took over Military Grade Coffee on December 29, 2020. The deal includes copyrights, the trademark of Military Grade Coffee, IP, and future revenues besides social media outlets like LinkedIn, Twitter, and Facebook businesses.
Conservative Broadcast already holds significant experience in the sales of coffee products through online channels like velloranicigars and thrashercoffee.
Acquires J. Vincent Creative Digital
In Q1 2021, Conservative Broadcast took over Atlanta, GA-based J. Vincent CDMA (Creative Digital Marketing Agency).
The established SEO/ Digital Marketing Agency expand the client base and capabilities of Conservative Broadcast. Following the deal, Conservative Broadcast will have access to the clients of J. Vincent Creative, team, web design, SEO competencies, and digital advertising.
Conservative Broadcast will also own an e-commerce channel, Christianrebelnation, product designs, and social media support portals, supply chain, customized software, and CRN e-mail list.
DeDonato Enterprises, the original marketing agency of Conservative Broadcast, will focus on politically conservative customers.
Jeff Evans, CEO of J. Vincent, and his team will focus on their clients’ sales and generate more leads. Several businesses hired J. Vincent in the past ten years and generated sales of several million.
Artificial Intelligence Technology Solutions (OTCMKTS:AITX) appoints CFO
Robotic Assistance Devices, Inc, a subsidiary of Artificial Intelligence Technology Solutions (OTCMKTS:AITX), inducted Anthony Brenz as a new CFO.
CEO and President of Robotic Assistance, Steve Reinharz, said the company is excited to induct Anthony into the team of Robotic Assistance. He will play an important role in the execution of its growth strategy.
The 20 years experience of Anthony helps the company to improve shareholder value. Anthony’s previous stints include operational and senior financial executive in heading operations and finance like supply chain, procurement, and corporate strategy besides customer service and human resources.
NewAge Inc. (NASDAQ:NBEV) Expanding Its Operations In Europe As Lucim™ Gets Recognition As A Safe Skincare Product
Post Views: 358 NewAge Inc. (NASDAQ:NBEV) announced a record net revenue increase in Europe, record attendance at its virtual events,...
ILUS International Inc. (OTCMKTS:ILUS) Appoints New Marketing Director Dejana Radonjic To Help With Global Marketing
Post Views: 315 ILUS International Inc. (OTCMKTS:ILUS) seems more focused on making new acquisitions, with about two accomplished within its...
Conservative Broadcast Media Journalism (OTCMKTS:CBMJ) Reports Revenues Of $2.4 Million In 2020
Post Views: 389 Conservative Broadcast Media Journalism (OTCMKTS:CBMJ) posted a robust growth of 118% YoY to $2.4 million in 2020. Development...
Cannabics Pharmaceuticals (OTCMKTS:CNBX) Initiates RCC-33 Dose-Response Study, And Cresco Labs (OTCMKTS:CRLBF) Launches Wonder Wellness Gummies
Post Views: 357 Cannabics Pharmaceuticals (OTCMKTS:CNBX) has announced that it will initiate a Dose-Response in-vivo Study in mice whose data...
Curaleaf Holdings Inc. (OTCMKTS:CURLF) Rebrands And Opens New Locations In Pennsylvania And Illinois
Post Views: 397 Curaleaf Holdings Inc. (OTCMKTS:CURLF) has announced new Curaleaf branding for its recently acquired retail locations and the...
Generex Biotechnology Corp’s (OTCMKTS:GNBT) NuGenerex Immuno-Oncology Responds To FDA Regarding Its Paediatric-Focused COVID-19 Vaccine
Post Views: 367 Generex Biotechnology Corp’s (OTCMKTS:GNBT) subsidiary NuGenerex Immuno-Oncology has announced the submission of a response to the FDA’s...